Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.

Yasuhiro Miyake, Yoshiaki Iwasaki, Akinobu Takaki, Haruhiko Kobashi, Kohsaku Sakaguchi, Yasushi Shiratori

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

OBJECTIVE: In Caucasian type 1 autoimmune hepatitis patients with a main susceptibility of human leukocyte antigen DR3 and DR4, elderly patients have a higher frequency of concurrent autoimmune disease and cirrhosis at presentation. However, in Japanese patients, the disease is dominantly associated with DR4, and their clinical features may be different from those of previous reports. In this study, we assessed the clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. METHODS: We investigated 160 consecutive patients with type 1 autoimmune hepatitis, consisting of 34 elderly patients (> or = 65 years) and 126 younger patients (<65 years). RESULTS: There were no differences in form of clinical onset, frequencies of concurrent autoimmune disease, positive proportions of anti-nuclear antibody and/or anti-smooth muscle antibody, and human leukocyte antigen DR status between the two groups. However, the elderly patients had lower serum levels of albumin (p=0.0049), and higher frequencies of cirrhosis (F4) and pre-cirrhosis (F3) (p=0.014) compared with the younger patients. In contrast, in elderly patients, the cumulative incidental rate of the normalization of serum alanine aminotransferase levels within 6 months after the introduction of initial treatment was higher in those treated with prednisolone > or = 20 mg/day than those treated only with ursodeoxycholic acid (p=0.001). CONCLUSION: We speculate that more years may pass between the occurrence of the disease and the presentation in Japanese elderly patients than in younger patients, and we considered that, even in elderly patients, those with advanced fibrosis should be treated with prednisolone in order to prevent progress of the disease into liver failure.

Original languageEnglish
Pages (from-to)1945-1949
Number of pages5
JournalInternal Medicine
Volume46
Issue number24
Publication statusPublished - 2007

Fingerprint

Autoimmune Hepatitis
Fibrosis
Ursodeoxycholic Acid
Liver Failure
HLA Antigens
Prednisolone
Autoimmune Diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Miyake, Y., Iwasaki, Y., Takaki, A., Kobashi, H., Sakaguchi, K., & Shiratori, Y. (2007). Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Internal Medicine, 46(24), 1945-1949.

Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. / Miyake, Yasuhiro; Iwasaki, Yoshiaki; Takaki, Akinobu; Kobashi, Haruhiko; Sakaguchi, Kohsaku; Shiratori, Yasushi.

In: Internal Medicine, Vol. 46, No. 24, 2007, p. 1945-1949.

Research output: Contribution to journalArticle

Miyake, Y, Iwasaki, Y, Takaki, A, Kobashi, H, Sakaguchi, K & Shiratori, Y 2007, 'Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.', Internal Medicine, vol. 46, no. 24, pp. 1945-1949.
Miyake, Yasuhiro ; Iwasaki, Yoshiaki ; Takaki, Akinobu ; Kobashi, Haruhiko ; Sakaguchi, Kohsaku ; Shiratori, Yasushi. / Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. In: Internal Medicine. 2007 ; Vol. 46, No. 24. pp. 1945-1949.
@article{2f070dc1a87d4649b723c580cc3aab8e,
title = "Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.",
abstract = "OBJECTIVE: In Caucasian type 1 autoimmune hepatitis patients with a main susceptibility of human leukocyte antigen DR3 and DR4, elderly patients have a higher frequency of concurrent autoimmune disease and cirrhosis at presentation. However, in Japanese patients, the disease is dominantly associated with DR4, and their clinical features may be different from those of previous reports. In this study, we assessed the clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. METHODS: We investigated 160 consecutive patients with type 1 autoimmune hepatitis, consisting of 34 elderly patients (> or = 65 years) and 126 younger patients (<65 years). RESULTS: There were no differences in form of clinical onset, frequencies of concurrent autoimmune disease, positive proportions of anti-nuclear antibody and/or anti-smooth muscle antibody, and human leukocyte antigen DR status between the two groups. However, the elderly patients had lower serum levels of albumin (p=0.0049), and higher frequencies of cirrhosis (F4) and pre-cirrhosis (F3) (p=0.014) compared with the younger patients. In contrast, in elderly patients, the cumulative incidental rate of the normalization of serum alanine aminotransferase levels within 6 months after the introduction of initial treatment was higher in those treated with prednisolone > or = 20 mg/day than those treated only with ursodeoxycholic acid (p=0.001). CONCLUSION: We speculate that more years may pass between the occurrence of the disease and the presentation in Japanese elderly patients than in younger patients, and we considered that, even in elderly patients, those with advanced fibrosis should be treated with prednisolone in order to prevent progress of the disease into liver failure.",
author = "Yasuhiro Miyake and Yoshiaki Iwasaki and Akinobu Takaki and Haruhiko Kobashi and Kohsaku Sakaguchi and Yasushi Shiratori",
year = "2007",
language = "English",
volume = "46",
pages = "1945--1949",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "24",

}

TY - JOUR

T1 - Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.

AU - Miyake, Yasuhiro

AU - Iwasaki, Yoshiaki

AU - Takaki, Akinobu

AU - Kobashi, Haruhiko

AU - Sakaguchi, Kohsaku

AU - Shiratori, Yasushi

PY - 2007

Y1 - 2007

N2 - OBJECTIVE: In Caucasian type 1 autoimmune hepatitis patients with a main susceptibility of human leukocyte antigen DR3 and DR4, elderly patients have a higher frequency of concurrent autoimmune disease and cirrhosis at presentation. However, in Japanese patients, the disease is dominantly associated with DR4, and their clinical features may be different from those of previous reports. In this study, we assessed the clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. METHODS: We investigated 160 consecutive patients with type 1 autoimmune hepatitis, consisting of 34 elderly patients (> or = 65 years) and 126 younger patients (<65 years). RESULTS: There were no differences in form of clinical onset, frequencies of concurrent autoimmune disease, positive proportions of anti-nuclear antibody and/or anti-smooth muscle antibody, and human leukocyte antigen DR status between the two groups. However, the elderly patients had lower serum levels of albumin (p=0.0049), and higher frequencies of cirrhosis (F4) and pre-cirrhosis (F3) (p=0.014) compared with the younger patients. In contrast, in elderly patients, the cumulative incidental rate of the normalization of serum alanine aminotransferase levels within 6 months after the introduction of initial treatment was higher in those treated with prednisolone > or = 20 mg/day than those treated only with ursodeoxycholic acid (p=0.001). CONCLUSION: We speculate that more years may pass between the occurrence of the disease and the presentation in Japanese elderly patients than in younger patients, and we considered that, even in elderly patients, those with advanced fibrosis should be treated with prednisolone in order to prevent progress of the disease into liver failure.

AB - OBJECTIVE: In Caucasian type 1 autoimmune hepatitis patients with a main susceptibility of human leukocyte antigen DR3 and DR4, elderly patients have a higher frequency of concurrent autoimmune disease and cirrhosis at presentation. However, in Japanese patients, the disease is dominantly associated with DR4, and their clinical features may be different from those of previous reports. In this study, we assessed the clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. METHODS: We investigated 160 consecutive patients with type 1 autoimmune hepatitis, consisting of 34 elderly patients (> or = 65 years) and 126 younger patients (<65 years). RESULTS: There were no differences in form of clinical onset, frequencies of concurrent autoimmune disease, positive proportions of anti-nuclear antibody and/or anti-smooth muscle antibody, and human leukocyte antigen DR status between the two groups. However, the elderly patients had lower serum levels of albumin (p=0.0049), and higher frequencies of cirrhosis (F4) and pre-cirrhosis (F3) (p=0.014) compared with the younger patients. In contrast, in elderly patients, the cumulative incidental rate of the normalization of serum alanine aminotransferase levels within 6 months after the introduction of initial treatment was higher in those treated with prednisolone > or = 20 mg/day than those treated only with ursodeoxycholic acid (p=0.001). CONCLUSION: We speculate that more years may pass between the occurrence of the disease and the presentation in Japanese elderly patients than in younger patients, and we considered that, even in elderly patients, those with advanced fibrosis should be treated with prednisolone in order to prevent progress of the disease into liver failure.

UR - http://www.scopus.com/inward/record.url?scp=38749085706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749085706&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 1945

EP - 1949

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 24

ER -